Bydgoszcz

Poland

707 total trials 270 recruiting

Filter these 707 trials by phase, condition, sponsor and more.

Open in Search →

A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Cabozantinib versus Sunitinib in Participants with Previously Untreated, … Ended

2023-509711-83-00 5 2017-10-27 Advanced or Metastatic Renal Cell Carcinoma
A Study of Nivolumab and Ipilimumab Combined with Chemotherapy Compared to Chemotherapy by Itself as the First Treatment Given for Stage IV … Ended

2023-508757-75-00 5 2017-09-18 Stage IV Non-Small Cell Lung Cancer (NSCLC)
A Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant Therapy … Ended

2022-501382-49-00 5 2017-03-07 Triple Negative Breast Cancer (TNBC)
The purpose of this study is to determine whether long-term RPC1063 is safe and effective in the treatment of ulcerative colitis (UC) Ended

2024-514815-92-00 5 2015-07-16 Ulcerative colitis
Phase 1/2 Study of Belzutifan Plus Palbociclib Versus Belzutifan in Advanced Renal Cell Carcinoma (RCC) Ended

2023-504963-17-00 9 Advanced ccRCC
APRILIAH (Aprogen Phase III Clinical Trial to Compare Efficacy, Safety, and Immunogenicity of AP063 in Subjects with HER2+ Breast Cancer) Ended

2023-506975-83-00 5 HER2-positive metastatic breast cancer (MBC) and early breast cancer (
A clinical study comparing different doses of a potential new medicine with an inactive medicine for patients with moderate to severe psoria … Ended

2023-508992-35-00 4 Plaque Psoriasis
A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneratio … Ended

2023-509206-29-00 5 Neovascular age-related macular degeneration (nAMD)
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart i … Ended

2024-512986-15-00 4 Sjögren’s Disease
A Study to Investigate Single Ascending Doses of Ocrelizumab for Safety and Side Effects, How The Body Handles It Over A Period of Time, How … Ended

2024-513639-26-00 3 Multiple Sclerosis (MS)
A randomized, phase 3 multicenter clinical trial to confirm the clinical efficacy and evaluate the safety of linaprazan glurate compared to … Ended

2025-522750-39-00 5 Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD)

Showing 697–707 of 707 trials